Visit our goGermline page to find out more about the technology and to view the full article.
goGermline is a revolutionary new technology to generate knockout and knock-in mouse models.
Ideal for compromised ES cells that normally would not give germline transmission, including repository ES cell clones.
Greatly improves animal welfare by addressing the 3R's: replace, reduce, refine. Licensing is available.
Ozgene is an Australian company that generates customised genetically modified mice for drug validation and medical research trials worldwide. Using Lean Management, we are able to efficiently and consistently provide our clients with high quality mouse models so that you too, can advance humanity and inspire curiosity.
Did you know that Ozgene’s founders, Dr Frank Koentgen and Dr Gabi Suess, were the first to successfully produce a C57BL/6 knockout mouse in 1993? Ozgene was founded in 1999 based on that initial accomplishment. Since then, we have established a long history of continued success. Today Ozgene is one of the leading companies providing genetically customised mice for researchers around the world.
Ozgene mice can be found all over the globe. This is evidenced by the distribution of published papers that reference mice created by Ozgene. We currently have over 300 papers published, more than any other competing company. We would love to add your paper to the list, so if you have a project in mind, please see our current services below and contact us for a confidential, obligation free assessment.
Over the past years we have been working on our organisational excellence framework. As a result, we have established a culture around our Vision & Mission (why), Strategy & Tactic (what) and Operations (how). One aspect, however, that has remained elusive is the gemba walk...
The scientific paper introducing our novel goGermline technology was published in genesis on 25 March 2016. Follow the link below to access the full article.
Back in 2011, Ozgene created two mouse models for the Hempel family, whose twin daughters suffer from a rare genetic cholesterol condition called Niemann-Pick Type C (NPC).
CRISPR technology is exciting and shows some promising results. It may reduce timelines to generate knock-in and knockout mice. CRISPR does, however, come with some drawbacks...